Fake diabetes, multivitamin medicines worth Rs 55 lakh for sale in Delhi, Haryana seized in Himachal Pradesh’s Baddi

Solan : Exposing yet another alleged laxity of the officers of the drug control department, a spurious drugs consignment having costing Rs 55 lakh was seized by a team of drug officials from a transport company vehicle and a pharmaceutical unit premises at Baddi on Sunday.

State Drugs Controller Navneet Marwaha confirmed that a transport godown of RS roadline located at Sai road in Baddi was raided where spurious drugs worth Rs 55 lakh of Sikkim-based Mankind and Intas Pharma pertaining to sugar and multivitamin tablets have been recovered. The said company did not have the license to manufacture these drugs and it had manufactured them in the name of the two companies.

Following this seizure, the manufacturing unit M/s Magnatek enterprise, where the drugs had been manufactured at Baddi was also raided and a huge stock of tablets and scrap were recovered by the team.

Raids were conducted throughout the night. The manufacturing premises of Magnatek enterprise have been sealed while the accused manufacture is absconding.

The vehicle of the transport company was seized in which medicines were being transported by the company. It was found that the firm had sold huge stock of spurious drugs in the market and department proceedings are under investigation to recover all material from the market informed Marwaha.

Drug controller Delhi has also been informed to seize the stock from a Central Delhi based wholesale trader whose bill was recovered from the transport company. The drugs were bound for Delhi and Haryana.

Involvement of other accused in the case is under investigation informed the officials.

Related Posts

  • Pharma
  • June 27, 2025
  • 138 views
Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners,…

  • Pharma
  • June 27, 2025
  • 125 views
Sun Pharma ropes in Richard Ascroft as North America CEO

Mumbai: Sun Pharma has announced the appointment of Richard Ascroft as the new North America (NAM) Chief Executive Officer (CEO). In a statement shared via LinkedIn, the company said, “We…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

MedTech Zone AMTZ Puts Vizag on the Science Map of India

MedTech Zone AMTZ Puts Vizag on the Science Map of India

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Sun Pharma ropes in Richard Ascroft as North America CEO

Sun Pharma ropes in Richard Ascroft as North America CEO

Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen

Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen